Schrodinger Inc

SDGR

Company Profile

  • Business description

    Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

  • Contact

    1540 Broadway
    24th Floor
    New YorkNY10036
    USA

    T: +1 212 295-5800

    https://www.schrodinger.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Health Information Services

    Fiscal Year End

    31 December 2026

    Employees

    850

Stocks News & Analysis

stocks

SpaceX is scaling AI infrastructure on earth, data centers in space might be next

Our view on the first results as a publicly traded company.
stocks

Investors too optimistic about overvalued ASX share

Upgraded first-half revenue guidance at the upper end of the previously announced range.
stocks

Restructuring at big four bank

Job cuts create capacity to invest as revenue growth slows.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,917.1039.50-0.44%
CAC 407,921.6883.191.06%
DAX 4025,645.04340.621.35%
Dow JONES (US)52,856.09360.210.69%
FTSE 10010,752.8819.880.19%
HKSE22,916.68735.19-3.11%
NASDAQ26,702.86278.041.05%
Nikkei 22562,907.841,713.40-2.65%
NZX 50 Index13,746.8414.45-0.11%
S&P 5007,757.1744.600.58%
S&P/ASX 2008,793.2038.10-0.43%
SSE Composite Index3,665.2747.75-1.29%

Market Movers